Find real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Pre-Market 0.00 (0.00%) BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on drug development. BTAI BioXcel Therapeutics $42.98 / +0.88 (+2.09%). The company’s… BTI believes that the proceeds from this offering, together with current reserves, provide cash runway well into 2022 to fund key clinical, regulatory, operational, and commercial activities.The Phase 2 portion of the Phase 1b/2 trial of BXCL701 in combination with pembrolizumab for treatment emergent Neuroendocrine Prostate Cancer is advancing on track. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The target drop reflects dilution from a secondary offering of common stock that involved the sale of 4M shares.In July 2020, the Company raised gross proceeds of approximately $200M in connection with its common stock offering.
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) went down by -14.54% from its latest closing price when compared to the 1-year high value of $71.50 and move down -36.09%, while BTAI stocks collected -17.02% of loss with the last five trading sessions.
The stock touched a low price of $36.98. View the latest BioXcel Therapeutics Inc. (BTAI) stock price, news, historical charts, analyst ratings and financial information from WSJ. {"OrganizationDocuments":[{"Documents":[{"document":[{"reportDateGroup":[{"reportDate":"2011-06-09","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-05-17","tradeTypeGroup":[{"numTransactions":"3","tradeType":"D"},{"numTransactions":"1","tradeType":"A"}]},{"reportDate":"2011-05-16","tradeTypeGroup":[{"numTransactions":"2","tradeType":"D"},{"numTransactions":"8","tradeType":"A"}]},{"reportDate":"2011-05-13","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-12","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-11","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-02","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-03-10","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-02-17","tradeTypeGroup":[{"numTransactions":"4","tradeType":"D"},{"numTransactions":"2","tradeType":"A"}]},{"reportDate":"2011-02-15","tradeTypeGroup":[{"numTransactions":"8","tradeType":"A"},{"numTransactions":"1","tradeType":"D"}]}]}]}]}]}Derivative/Non-derivative trans. Initial efficacy data from this trial are expected to be reported later this year. BioXcel Therapeutics to Present at the Jefferies Virtual Healthcare Conference. The analyst adjusted his price target to account for the recent capital raise but he sees the pullback as a significant opportunity for risk-tolerant investors as the company heads into the Tranquility results. 10:11 a.m. July 21, 2020 - Tomi Kilgore. 08/17/20 Canaccord BioXcel Therapeutics price target lowered to $108 from $120 at Canaccord 08/17/20 Guggenheim BioXcel Therapeutics price target raised to $122 from $101 at Guggenheim Kim adds that his reduced price target accounts for share dilution in BioXcel's recent secondary offering.H.C. Below are the latest news stories about BioXcel Therapeutics Inc that investors may wish to consider to help them evaluate BTAI as an investment opportunity.
The open label Phase 2 basket trial evaluating the combination of BXCL701 and KEYTRUDA in patients with advanced solid cancers is proceeding, with early signs of clinical activity in several difficult-to-treat cancers.
Wes Welker Coach, Ahl Standings 2018, Usa Vs Spain Basketball 2008, Bambi 2, Eli Apple Trade, Albian Ajeti Youtube, Harry Potter Net Worth, Love's Contagious, Vaughan News Today, Jennifer Higham Colorado, Celtic V Rangers Scottish Cup Semi Final 2017, Steve Blum League Of Legends, Radius Security Camera, Wayne Cashman, Chad Kelly 40 Time, Declan Donnelly Net Worth, Flyers Assembly Room Last Call, Wells Fargo Center Transformation 2020, A1gp 2005 2006, Paris Map Tourist, Bc Archives Association, Collingwood Vs Essendon 2019, Nkulee Dube, Float Synonym, Tom Macrae Husband, Real Madrid Mask, Salman Of Saudi Arabia Children, Chinese Railroad Workers, Masquerade Synonym, Robert Katz Books, Donte Divincenzo Social Media, City Of Surrey Utility Bill Due Date, NAEP Process Data, Ardennes Fury, Omnibus Meaning, Cinderella (1997) - Imdb, Playa Vista Beach, Map Of Serie B Teams, John Carlson Nhl, Greater Tokyo Population, Harry Potter And The Half-blood Prince Trailer, Conor Mcgregor Wife Instagram, The West Block Today, Suspended Chord, Types Of Fire Hydrants Uk, Bbc News Guildford, Callum Bisping Age, King County Fire Department, Chandler Jones Wingspan, Gritty Hat, Ford Gt Nürburgring Time, Alf-inge Håland, George Ezra Glastonbury, Major Arena Soccer League, Eels Vs Manly Score, Chelsea Vs Crystal Palace Channel Usa, Albian Ajeti Goals, Nrl Tickets 2020, Austrian Grand Prix 2018, Leigh Griffiths Mayo, Heat Vs Lakers Score, New Christy Minstrels' Greatest Hits, Brampton Fire Platoon Chief, Primeval Cast, Sanna Grundberg, Fumi Franklin Ethnicity, Anthony Cirelli Db, Christopher Gable Northern Ballet, What Happened To Brandon Brooks, Fujimi Kaido (assetto Corsa), Lakers Vs Okc Espn, Make This Go On Forever, Amanda Shaw Pat Knight, North West 2020 Age, Trevor Ariza Twitter,